Logo Kenvue Inc. - KVUE 24.18 USD

P/E
38.28
EPS
0.57
Yield
3.43%
P/B
4.11
ROE
10.55
Target Price
22.07 USD

24.180 USD

24.180 USD

Daily: +0.29%
Key Metrics

P/E: 38.28

EPS: 0.57

Book Value: 5.32

Price to Book: 4.11

Debt/Equity: 84.56

% Insiders: 0.022%

Growth

Revenue Growth: 0.00%

Earnings Growth: -0.87%

Estimates

Forward P/E: 17.74

Forward EPS: 1.23

Target Mean Price: 22.07

Dividend

Dividend Yield: 3.43%

Annual dividends: 0.82 USD

Ex-Div. Date: May 14, 2025

Payout: 145.54%

 Logo About Kenvue Inc. - (KVUE)

Country: United States

Sector: Consumer Defensive

Website: https://www.kenvue.com

Kenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands. The Skin Health and Beauty segment provides face and body care, hair, sun, and other care products under the Neutrogena, Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Rogaine, and OGX brand names. The Essential Health segment offers oral and baby, women's health, wound, and other care products under the Listerine, Johnson's, Band-Aid, and Stayfree, o.b., tampons, Carefree, and Desitin Diaper Rash brands. The company was incorporated in 2022 and is headquartered in Skillman, New Jersey.

Dividend Yield

3.43%

Annual Dividends

0.82 USD

Next ex. div date

May 14, 2025

Payout Ratio

145.54%

Historical Dividends
Year Total Dividends
2026 0.21 USD
2025 0.82 USD
2024 0.81 USD
2023 0.40 USD

Yearly aggregated dividends

Dividends

Kenvue Inc.
May 28, 2025 Upcoming
Dividend
0.205 USD
Kenvue Inc.
Feb 26, 2025 Paid
Dividend
0.205 USD
Kenvue Inc.
Nov 27, 2024 Paid
Dividend
0.205 USD
Kenvue Inc.
Aug 28, 2024 Paid
Dividend
0.205 USD

Historical Split Corporate Actions

Trades
My Trades
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion